A marked increase in myeloblasts in the peripheral blood of a patient with Burkitt lymphoma following granulocyte colony-stimulating factor administration

Acta Haematol. 2008;120(3):174-6. doi: 10.1159/000181184. Epub 2008 Dec 10.

Authors

Hiroyuki Takamatsu¹, Hirohito Yamazaki, Takeshi Yamashita, Akiyoshi Takami, Hirokazu Okumura, Shinji Nakao

Affiliation

¹ Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. takamaz@med3.m.kanazawa-u.ac.jp

PMID: 19066424
DOI: 10.1159/000181184

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antigens, CD / metabolism
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Burkitt Lymphoma / blood*
Burkitt Lymphoma / drug therapy*
Burkitt Lymphoma / metabolism
Burkitt Lymphoma / pathology
Fatal Outcome
Filgrastim
Granulocyte Colony-Stimulating Factor / administration & dosage*
Granulocyte Precursor Cells* / metabolism
Granulocyte Precursor Cells* / pathology
Humans
Leukocyte Count
Male
Recombinant Proteins
Time Factors

Substances

Antigens, CD
Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Filgrastim